^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.TARGET_1            
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             35    10631001 10631002 10631003    
                           11601006 11601007 13031001    
                           13031004 13581001 13581014    
                           13991002 13991004 13991007    
                           13991009 13991010 16591001    
                           16591003 16591006 17601002    
                           17601003 17601005 17601007    
                           17601012 17601014 17601025    
                           17661002 17661004 17661006    
                           19691001 19731001 19731002    
                           19731006 19831001 19831005    
                           19831008 19901003             
      AVISITN         2    4 12                          
      SSNRISN         2    1 2                           
      trtn            3    1 2 3                         
 
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Covariance Parameters             3
              Columns in X                     21
              Columns in Z                      0
              Subjects                         35
              Max Obs per Subject               2


                    Number of Observations

          Number of Observations Read              60
          Number of Observations Used              60
          Number of Observations Not Used           0


 
 
 
 
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       417.51814469                
          1              2       411.06492907      0.00017187
          2              1       411.03584017      0.00000170
          3              1       411.03556736      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           147.24
                UN(2,1)     id          71.5003
                UN(2,2)     id           114.81
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                        Fit Statistics

             -2 Res Log Likelihood           411.0
             AIC (Smaller is Better)         417.0
             AICC (Smaller is Better)        417.6
             BIC (Smaller is Better)         421.7


                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   2          6.48          0.0391


 
 
 
 
 
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                          Num     Den
      Effect               DF      DF    F Value    Pr > F

      BASE                  1    29.6      12.58    0.0013
      trtn                  2    26.8       0.03    0.9732
      AVISITN               1    22.4       2.54    0.1252
      AVISITN*trtn          2    21.6       0.40    0.6734
      BASE*AVISITN          1    22.8       1.24    0.2764
      SSNRISN               1    27.4       0.00    0.9798
      AVISITN*SSNRISN       1    21.8       1.71    0.2040


                      Least Squares Means
 
                Analysis                       Standard
 Effect         Visit (N)    trtn   Estimate      Error     DF

 AVISITN*trtn            4   1      -17.0399     4.3284   28.2
 AVISITN*trtn            4   2      -14.3010     3.8461   28.7
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                Analysis                       Standard
 Effect         Visit (N)    trtn   Estimate      Error     DF

 AVISITN*trtn            4   3      -16.2738     4.0222   28.2
 AVISITN*trtn           12   1      -20.9973     4.4543   23.4
 AVISITN*trtn           12   2      -21.9374     3.7289   22.8
 AVISITN*trtn           12   3      -19.7561     4.1410   23.4

                      Least Squares Means
 
                Analysis
 Effect         Visit (N)    trtn   t Value   Pr > |t|    Alpha

 AVISITN*trtn            4   1        -3.94     0.0005     0.05
 AVISITN*trtn            4   2        -3.72     0.0009     0.05
 AVISITN*trtn            4   3        -4.05     0.0004     0.05
 AVISITN*trtn           12   1        -4.71     <.0001     0.05
 AVISITN*trtn           12   2        -5.88     <.0001     0.05
 AVISITN*trtn           12   3        -4.77     <.0001     0.05
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                   Analysis
    Effect         Visit (N)    trtn      Lower       Upper

    AVISITN*trtn            4   1      -25.9034     -8.1764
    AVISITN*trtn            4   2      -22.1704     -6.4315
    AVISITN*trtn            4   3      -24.5099     -8.0377
    AVISITN*trtn           12   1      -30.2031    -11.7915
    AVISITN*trtn           12   2      -29.6549    -14.2200
    AVISITN*trtn           12   3      -28.3145    -11.1977


              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           4  1              4  2       -2.7389
  AVISITN*trtn           4  1              4  3       -0.7661
  AVISITN*trtn           4  1             12  1        3.9574
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Estimate

  AVISITN*trtn           4  1             12  2        4.8975
  AVISITN*trtn           4  1             12  3        2.7162
  AVISITN*trtn           4  2              4  3        1.9728
  AVISITN*trtn           4  2             12  1        6.6963
  AVISITN*trtn           4  2             12  2        7.6364
  AVISITN*trtn           4  2             12  3        5.4551
  AVISITN*trtn           4  3             12  1        4.7235
  AVISITN*trtn           4  3             12  2        5.6636
  AVISITN*trtn           4  3             12  3        3.4823
  AVISITN*trtn          12  1             12  2        0.9401
  AVISITN*trtn          12  1             12  3       -1.2412
  AVISITN*trtn          12  2             12  3       -2.1813

 
 
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis           Standard
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Error

  AVISITN*trtn           4  1              4  2        5.2625
  AVISITN*trtn           4  1              4  3        5.4554
  AVISITN*trtn           4  1             12  1        4.5153
  AVISITN*trtn           4  1             12  2        5.4533
  AVISITN*trtn           4  1             12  3        5.7801
  AVISITN*trtn           4  2              4  3        4.9121
  AVISITN*trtn           4  2             12  1        5.6321
  AVISITN*trtn           4  2             12  2        3.8736
  AVISITN*trtn           4  2             12  3        5.3242
  AVISITN*trtn           4  3             12  1        5.7910
  AVISITN*trtn           4  3             12  2        5.1574
  AVISITN*trtn           4  3             12  3        4.2047
  AVISITN*trtn          12  1             12  2        5.1605
  AVISITN*trtn          12  1             12  3        5.4353
  AVISITN*trtn          12  2             12  3        4.8986

 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

               Differences of Least Squares Means
 
              Analysis          Analysis
Effect        Visit (N)   trtn  Visit (N)   _trtn    DF  t Value

AVISITN*trtn           4  1              4  2      28.5    -0.52
AVISITN*trtn           4  1              4  3      28.2    -0.14
AVISITN*trtn           4  1             12  1      21.4     0.88
AVISITN*trtn           4  1             12  2      46.7     0.90
AVISITN*trtn           4  1             12  3      46.7     0.47
AVISITN*trtn           4  2              4  3      28.7     0.40
AVISITN*trtn           4  2             12  1      45.1     1.19
AVISITN*trtn           4  2             12  2      21.7     1.97
AVISITN*trtn           4  2             12  3      47.1     1.02
AVISITN*trtn           4  3             12  1      45.2     0.82
AVISITN*trtn           4  3             12  2      47.8     1.10
AVISITN*trtn           4  3             12  3      21.6     0.83
AVISITN*trtn          12  1             12  2      22.9     0.18
AVISITN*trtn          12  1             12  3        23    -0.23
AVISITN*trtn          12  2             12  3      23.2    -0.45

 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn  Pr > |t|

  AVISITN*trtn           4  1              4  2        0.6068
  AVISITN*trtn           4  1              4  3        0.8893
  AVISITN*trtn           4  1             12  1        0.3905
  AVISITN*trtn           4  1             12  2        0.3737
  AVISITN*trtn           4  1             12  3        0.6406
  AVISITN*trtn           4  2              4  3        0.6909
  AVISITN*trtn           4  2             12  1        0.2407
  AVISITN*trtn           4  2             12  2        0.0616
  AVISITN*trtn           4  2             12  3        0.3108
  AVISITN*trtn           4  3             12  1        0.4190
  AVISITN*trtn           4  3             12  2        0.2776
  AVISITN*trtn           4  3             12  3        0.4166
  AVISITN*trtn          12  1             12  2        0.8570
  AVISITN*trtn          12  1             12  3        0.8214
  AVISITN*trtn          12  2             12  3        0.6602

 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                 Analysis          Analysis
   Effect        Visit (N)   trtn  Visit (N)   _trtn   Alpha

   AVISITN*trtn           4  1              4  2        0.05
   AVISITN*trtn           4  1              4  3        0.05
   AVISITN*trtn           4  1             12  1        0.05
   AVISITN*trtn           4  1             12  2        0.05
   AVISITN*trtn           4  1             12  3        0.05
   AVISITN*trtn           4  2              4  3        0.05
   AVISITN*trtn           4  2             12  1        0.05
   AVISITN*trtn           4  2             12  2        0.05
   AVISITN*trtn           4  2             12  3        0.05
   AVISITN*trtn           4  3             12  1        0.05
   AVISITN*trtn           4  3             12  2        0.05
   AVISITN*trtn           4  3             12  3        0.05
   AVISITN*trtn          12  1             12  2        0.05
   AVISITN*trtn          12  1             12  3        0.05
   AVISITN*trtn          12  2             12  3        0.05

 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Lower

  AVISITN*trtn           4  1              4  2      -13.5095
  AVISITN*trtn           4  1              4  3      -11.9373
  AVISITN*trtn           4  1             12  1       -5.4208
  AVISITN*trtn           4  1             12  2       -6.0749
  AVISITN*trtn           4  1             12  3       -8.9138
  AVISITN*trtn           4  2              4  3       -8.0782
  AVISITN*trtn           4  2             12  1       -4.6467
  AVISITN*trtn           4  2             12  2       -0.4031
  AVISITN*trtn           4  2             12  3       -5.2550
  AVISITN*trtn           4  3             12  1       -6.9391
  AVISITN*trtn           4  3             12  2       -4.7072
  AVISITN*trtn           4  3             12  3       -5.2476
  AVISITN*trtn          12  1             12  2       -9.7377
  AVISITN*trtn          12  1             12  3      -12.4852
  AVISITN*trtn          12  2             12  3      -12.3111

 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.1.1
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Primary Effic
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

              Differences of Least Squares Means
 
                Analysis          Analysis
  Effect        Visit (N)   trtn  Visit (N)   _trtn     Upper

  AVISITN*trtn           4  1              4  2        8.0317
  AVISITN*trtn           4  1              4  3       10.4051
  AVISITN*trtn           4  1             12  1       13.3356
  AVISITN*trtn           4  1             12  2       15.8699
  AVISITN*trtn           4  1             12  3       14.3462
  AVISITN*trtn           4  2              4  3       12.0239
  AVISITN*trtn           4  2             12  1       18.0393
  AVISITN*trtn           4  2             12  2       15.6759
  AVISITN*trtn           4  2             12  3       16.1652
  AVISITN*trtn           4  3             12  1       16.3860
  AVISITN*trtn           4  3             12  2       16.0343
  AVISITN*trtn           4  3             12  3       12.2122
  AVISITN*trtn          12  1             12  2       11.6180
  AVISITN*trtn          12  1             12  3       10.0028
  AVISITN*trtn          12  2             12  3        7.9485
 
 
^S={}CAPS-5: Clinician Administered PTSD Scale; CAPS-5 total sco
^S={}Note:The Modified Full Analysis Set includes all participan
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note:The CAPS-5 total score is the sum of the 20 item-score
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: The LS means, SE, LS Mean Diff, 95% CI and p-value ha
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
